Tacklng the EML4/ALK Fusion Oncogenes in Murine Models.

被引：0
|
作者：
Hawes, J. [1 ]
Vilimas, T. [1 ]
Collins, K. [1 ]
Kozlov, S. [1 ]
机构：
[1] SAIC Frederick Inc, CAPR, FNLCR, Frederick, MD 21702 USA
来源：
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL | 2015年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A-2007
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] EML4-ALK AND OTHER FUSION KINASES IN LUNG CANCER
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S438 - S438
  • [42] Simultaneous detection of ALK gene and protein in NSCLC biopsies using FISHbreak apart and ALK/EML4 fusion probe and anti-ALK D5F3 rabbit monoclononal antibody
    Plank, L.
    Barthova, M.
    Balharek, T.
    Farkasova, A.
    Hutka, Z.
    Janakova, L.
    Kviatkovska, Z.
    Scheerova, K.
    VIRCHOWS ARCHIV, 2015, 467 : S42 - S42
  • [43] EML4-ALK FUSION GENE IN LUNG ADENOCARCINOMA IN THAILAND
    Prempree, Thongbliew
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1023 - S1024
  • [44] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
  • [45] Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
    Heuckmann, Johannes M.
    Balke-Want, Hyatt
    Malchers, Florian
    Peifer, Martin
    Sos, Martin L.
    Koker, Mirjam
    Meder, Lydia
    Lovly, Christine M.
    Heukamp, Lukas C.
    Pao, William
    Kueppers, Ralf
    Thomas, Roman K.
    CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4682 - 4690
  • [46] Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
    Emily K. Kleczko
    Trista K. Hinz
    Teresa T. Nguyen
    Natalia J. Gurule
    Andre Navarro
    Anh T. Le
    Amber M. Johnson
    Jeff Kwak
    Diana I. Polhac
    Eric T. Clambey
    Mary Weiser-Evans
    Daniel T. Merrick
    Michael C. Yang
    Tejas Patil
    Erin L. Schenk
    Lynn E. Heasley
    Raphael A. Nemenoff
    npj Precision Oncology, 7
  • [47] Durable responses to alectinib in murine models of EML4-ALK lung cancer requires adaptive immunity
    Kleczko, Emily K.
    Hinz, Trista K.
    Nguyen, Teresa T.
    Gurule, Natalia J.
    Navarro, Andre
    Le, Anh T.
    Johnson, Amber M.
    Kwak, Jeff
    Polhac, Diana I.
    Clambey, Eric T.
    Weiser-Evans, Mary
    Merrick, Daniel T.
    Yang, Michael C.
    Patil, Tejas
    Schenk, Erin L.
    Heasley, Lynn E.
    Nemenoff, Raphael A.
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [48] 非小细胞肺癌ALK融合基因非EML4伙伴的故事
    魏雨晴
    许春伟
    宋勇
    循证医学, 2018, 18 (05) : 257 - 259
  • [49] Overcoming the resistance to Crizotinib in patients with Non-Small Cell Lung Cancer harboring EML4/ALK translocation
    Perez, Cesar A.
    Velez, Michel
    Raez, Luis E.
    Santos, Edgardo S.
    LUNG CANCER, 2014, 84 (02) : 110 - 115
  • [50] EML4/ALK Status in Lung Cancer - A 2 Year Experience from a Tertiary Care Cancer Centre in India
    Murthy, Sudha S.
    Rajappa, Senthil J.
    Gundimeda, Sandhya D.
    Mallavarapu, Krishna M.
    Ayyagari, Santa
    Raju, K. V.
    Rao, Thamineedi S.
    Fonseca, Daphne
    Koppula, Veeraiah
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S693 - S693
12345